Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

NASA’s Mars Sample Return program faces opposition from planetary scientists following proposed cancellation, with concerns raised over Perseverance samples, future Mars missions, and international ...

ATRIMED today shared an update on a long running research effort led in part by physician scientist Dr. Latha Damle, whose ...

ExLabs partners with Japan’s Chiba Institute of Technology (ChibaTech) and its Planetary Exploration Research Center (PERC) ...

AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...

ChibaTech's instrument package includes a multiband imaging camera onboard the ExLabs mothership and deployable Cubesat-shaped landers (called CubeLanders), designed to study the asteroid's surface ...

The United States military has quietly locked in a sweeping artificial intelligence partnership with Elon Musk's startup xAI, ...

Commonwealth Charter Academy's growth presents a challenge to Pa.'s traditional public schools. But lawsuits and budget cuts ...

Newquay-based Green Park Pharma, which specialises in developing liquid formulations of existing medications, has completed a multimillion-pound funding round.

KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly improve survival in combat and emergency medicine. Severe blood loss ...

As a medical negligence legal specialist, I must express grave concern about the recurring incidents of absolutely ...